DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 58 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $59,712,000 | +191.9% | 1,600,000 | +100.0% | 0.39% | +49.8% |
| Q1 2021 | $20,456,000 | +16.1% | 800,000 | 0.0% | 0.26% | +37.0% |
| Q4 2020 | $17,624,000 | +22.5% | 800,000 | 0.0% | 0.19% | -10.0% |
| Q3 2020 | $14,392,000 | -29.2% | 800,000 | 0.0% | 0.21% | -36.2% |
| Q2 2020 | $20,320,000 | +2427.4% | 800,000 | +2092.0% | 0.33% | +1956.2% |
| Q4 2019 | $804,000 | +200.0% | 36,496 | -27.0% | 0.02% | -33.3% |
| Q1 2016 | $268,000 | -54.9% | 50,000 | 0.0% | 0.02% | -45.5% |
| Q4 2015 | $594,000 | -27.7% | 50,000 | -50.0% | 0.04% | +33.3% |
| Q3 2015 | $822,000 | +17.8% | 100,000 | +100.0% | 0.03% | -21.4% |
| Q2 2015 | $698,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |